Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity

In this report, we present a case study of how pharmacogenomics and pharmacometabolomics can be useful to characterize safety and pharmacokinetic profiles in early phase new drug development clinical trials. During conducting a first-in-human trial for a new molecular entity, we were able to determi...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Genomics Inform
Главные авторы: Oh, Jaeseong, Yi, Sojeong, Gu, Namyi, Shin, Dongseong, Yu, Kyung-Sang, Yoon, Seo Hyun, Cho, Joo-Youn, Jang, In-Jin
Формат: Artigo
Язык:Inglês
Опубликовано: Society of Gastrointestinal Intervention 2018
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6187817/
https://ncbi.nlm.nih.gov/pubmed/30309203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5808/GI.2018.16.3.52
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы